A L Hyman

3.2k total citations · 2 hit papers
26 papers, 2.6k citations indexed

About

A L Hyman is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A L Hyman has authored 26 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A L Hyman's work include Nitric Oxide and Endothelin Effects (14 papers), Pulmonary Hypertension Research and Treatments (9 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). A L Hyman is often cited by papers focused on Nitric Oxide and Endothelin Effects (14 papers), Pulmonary Hypertension Research and Treatments (9 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). A L Hyman collaborates with scholars based in United States and France. A L Hyman's co-authors include L J Ignarro, P J Kadowitz, Howard Lippton, Jo C. W. Edwards, Carl A. Gruetter, William H. Baricos, PJ Kadowitz, Icilio Cavero, P. J. Kadowitz and S. D. Cook and has published in prestigious journals such as Blood, Journal of Bone and Joint Surgery and Journal of Applied Physiology.

In The Last Decade

A L Hyman

26 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.

1981 1.4k citations L J Ignarro, Howard Lippton et al. Journal of Pharmacology and Experimental Therapeutics profile →
Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators

1981 520 citations L J Ignarro, A L Hyman et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A L Hyman United States	16	1.8k	830	599	493	271	26	2.6k
William H. Baricos United States	24	1.4k 0.8×	605 0.7×	484 0.8×	897 1.8×	263 1.0×	44	3.1k
H. F. Hodson United Kingdom	16	2.2k 1.3×	1.0k 1.2×	664 1.1×	736 1.5×	226 0.8×	32	3.4k
Carl A. Gruetter United States	23	2.5k 1.4×	1.1k 1.3×	782 1.3×	785 1.6×	355 1.3×	43	3.6k
Paul R. Myers United States	27	2.0k 1.1×	1.5k 1.8×	645 1.1×	614 1.2×	276 1.0×	65	3.4k
R.J. Gryglewski Poland	23	1.1k 0.6×	701 0.8×	593 1.0×	412 0.8×	183 0.7×	56	2.4k
P J Kadowitz United States	22	2.9k 1.6×	1.3k 1.6×	938 1.6×	877 1.8×	402 1.5×	33	4.2k
A.H. Henderson United Kingdom	22	1.1k 0.6×	1.1k 1.3×	283 0.5×	387 0.8×	255 0.9×	45	2.2k
J. Stadler Germany	22	1.7k 1.0×	288 0.3×	843 1.4×	697 1.4×	245 0.9×	39	3.1k
Yoshiki Yui Japan	32	947 0.5×	991 1.2×	305 0.5×	673 1.4×	143 0.5×	91	3.0k
J Loscalzo United States	20	1.8k 1.0×	1.2k 1.5×	496 0.8×	504 1.0×	121 0.4×	32	3.7k

Countries citing papers authored by A L Hyman

Since Specialization

Citations

This map shows the geographic impact of A L Hyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A L Hyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A L Hyman more than expected).

Fields of papers citing papers by A L Hyman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A L Hyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A L Hyman. The network helps show where A L Hyman may publish in the future.

Co-authorship network of co-authors of A L Hyman

This figure shows the co-authorship network connecting the top 25 collaborators of A L Hyman. A scholar is included among the top collaborators of A L Hyman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A L Hyman. A L Hyman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Deng, Weiwen, et al.. (2004). Antiproliferative effects of calcitonin gene-related peptide in aortic and pulmonary artery smooth muscle cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 288(1). L202–L211. 47 indexed citations

2.

Cai, Biao, et al.. (1995). Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.. PubMed. 328(2). 165–79. 3 indexed citations

3.

Lippton, Howard, et al.. (1990). Vasodilator activity of endothelin-1 and endothelin-3: rapid development of cross-tachyphylaxis and dependence on the rate of endothelin administration.. Journal of Pharmacology and Experimental Therapeutics. 254(3). 1024–1028. 41 indexed citations

4.

Brinker, Mark R., Howard Lippton, S. D. Cook, & A L Hyman. (1990). Pharmacological regulation of the circulation of bone.. Journal of Bone and Joint Surgery. 72(7). 964–975. 66 indexed citations

5.

Kadowitz, Philip J., et al.. (1988). Inhibitory effects of diltiazem on vasoconstrictor responses in the cat.. Journal of Pharmacology and Experimental Therapeutics. 244(1). 84–90. 5 indexed citations

6.

Ignarro, L J, K S Wood, Michael S. Wolin, et al.. (1985). Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate.. Journal of Pharmacology and Experimental Therapeutics. 233(3). 560–569. 43 indexed citations

7.

Edwards, Jo C. W., L J Ignarro, A L Hyman, & Philip J. Kadowitz. (1984). Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.. Journal of Pharmacology and Experimental Therapeutics. 228(1). 33–42. 53 indexed citations

8.

Kerstein, Morris D., et al.. (1984). Prostacyclin synthetase activity in diabetic human venous tissue.. PubMed. 96(2). 179–83. 6 indexed citations

9.

Ignarro, L J, Howard Lippton, Jo C. W. Edwards, et al.. (1981). Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.. Journal of Pharmacology and Experimental Therapeutics. 218(3). 739–749. 1381 indexed citations breakdown →

10.

Ignarro, L J, et al.. (1981). Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 57(5). 946–955. 520 indexed citations breakdown →

11.

Ignarro, L J, et al.. (1981). Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 57(5). 946–955. 24 indexed citations

12.

Kadowitz, P J & A L Hyman. (1980). Comparative effects of thromboxane B2 on the canine and feline pulmonary vascular bed.. Journal of Pharmacology and Experimental Therapeutics. 213(2). 300–305. 26 indexed citations

13.

Chapnick, B. M., Larry P. Feigen, A L Hyman, & P. J. Kadowitz. (1978). Differential effects of prostaglandins in the mesenteric vascular bed. American Journal of Physiology-Heart and Circulatory Physiology. 235(3). H326–H332. 35 indexed citations

14.

Spannhake, E. W., et al.. (1978). Analysis of airway effects of a PGH2 analog in the anesthetized dog. Journal of Applied Physiology. 44(3). 406–415. 10 indexed citations

15.

Kadowitz, P J, et al.. (1975). Influence of prostaglandins E1 and F2alpha on pulmonary vascular resistance, isolated lobar vessels and cyclic nucleotide levels.. Journal of Pharmacology and Experimental Therapeutics. 192(3). 677–687. 52 indexed citations

16.

Hughes, John P., et al.. (1975). Actions of Prostaglandins E1 and F2 on Isolated Intrapulmonary Vascular Smooth Muscle. Experimental Biology and Medicine. 150(2). 414–421. 13 indexed citations

17.

Goldberg, Michael R., et al.. (1975). Unusual Venoconstrictor Effects of Angiotensin . Experimental Biology and Medicine. 149(3). 707–713. 4 indexed citations

18.

Pennington, D G, A L Hyman, & William E. Jaques. (1973). Pulmonary vascular response to endotoxin in intact dogs.. PubMed. 73(2). 246–55. 26 indexed citations

19.

Hyman, A L, D G Pennington, & PJ Kadowitz. (1973). Effect of acute pulmonary edema on pulmonary arterial pressure in intact dogs. American Journal of Physiology-Legacy Content. 224(1). 35–39. 5 indexed citations

20.

Hyman, A L. (1966). The Pulmonary Veins. Annual Review of Medicine. 17(1). 431–446. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact